Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion type Assertion NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_head.
- NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion description "[Similarly, U87MG cells engineered to overexpress TIMP-2 at the same levels as U87-C1 cells also demonstrated increased MMP-2 activation, indicating that an increase in physiological levels of TIMP-2 can promote MMP-2 activation and invasion in glioblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_provenance.
- NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion evidence source_evidence_literature NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_provenance.
- NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion SIO_000772 14631378 NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_provenance.
- NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion wasDerivedFrom befree-20150227 NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_provenance.
- NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_assertion wasGeneratedBy ECO_0000203 NP561630.RAonMbqAIlL-18LWrfHnyRCHhRfQ5L59tofSI4-KlaCXI130_provenance.